19:25:03 EDT Tue 21 Jul 2026
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Rocket Doctor AI Inc
Symbol AIDR
Shares Issued 80,584,398
Close 2025-09-09 C$ 0.69
Market Cap C$ 55,603,235
Recent Sedar+ Documents

Rocket Doctor hits 50-pharmacy milestone in Canada

2025-09-09 18:41 ET - News Release

Dr. Essam Hamza reports

ROCKET DOCTOR'S PHARMACY PROGRAM ACHIEVES 50-LOCATION MILESTONE, DELIVERING CARE WHERE PATIENTS ARE

Rocket Doctor AI Inc.'s wholly owned digital health platform and marketplace, Rocket Doctor Inc., has surpassed a major milestone with the expansion of its pharmacy-based virtual care and diagnostic devices program to 50 independently owned pharmacies across Canada with appointments covered by provincial insurance.

  • The program integrates Rocket Doctor's physician-led, artificial-intelligence-powered virtual care platform directly into community pharmacies, largely in rural and underserved parts of Canada.
  • Pharmacy partners have supported 16,500-plus appointments, with 75 per cent resulting in prescriptions, nearly all filled at the originating pharmacy.
  • Building on its Canadian success, Rocket Doctor has extended the model to the United States, equipping community health care workers in inner-city New York with connected devices, and is in discussions with federally qualified health centres (FQHCs) to broaden access.

Through this innovative program, pharmacies are equipped with either virtual care stations with bluetooth-enabled diagnostic tools and/or digital clinics, which provide a dedicated booking page and QR code that guide patients into a virtual visit using their own device. To date, 12 pharmacies are actively operating virtual care stations, with the remainder offering digital clinics, giving communities flexible pathways into care.

Both models enable patients to access Rocket Doctor's physician-led platform directly from their local pharmacy. Using secure video and audio connections, patients can quickly connect with licensed physicians, receive assessments and have prescriptions filled on site. Services include urgent care, as well as comprehensive family medicine, which includes items such as women's health, men's health, chronic disease management, sexual health, specialist referrals, labs, imaging and preventative/public health screenings. In Ontario, specialist services also include addictions medicine, psychiatry and over a dozen other specialties, completely covered by provincial health insurance.

"Almost every community across Canada has a pharmacist, and their work is being increasingly recognized as central to Canada's health care system. This program empowers pharmacists to play an even greater role in delivering front-line care, but supported by a robust interdisciplinary team-based model," said Dr. William Cherniak, chief executive officer of Rocket Doctor Inc. "By integrating our digital health platform and marketplace into pharmacies, we're not only giving patients faster access to clinical services but also strengthening the role of pharmacists as trusted, accessible health care partners."

Across Rocket Doctor's pharmacy network, more than 16,500 appointments have been completed, with approximately 75 per cent resulting in prescriptions, 99 per cent of which were filled at the patient's originating pharmacy at the patient's request. These results demonstrate how pharmacies, especially in rural and underserved areas, can help address Canada's health care access gaps by working hand in hand with physicians in innovative hybridized in-person, virtual and cloud-based models of care.

Patients in rural communities are already seeing the benefits of the program. At a pharmacy in Stony Plain, Alta., more than 530 appointments have been completed since launch, resulting in 424 prescriptions filled directly at the pharmacy. The program is helping to reduce unnecessary ER visits and strengthen continuity of care for residents in a community where access to family physicians remains limited.

Building on its success in Canada, Rocket Doctor has expanded the model to the United States, equipping three housing complexes and community health care workers in inner-city New York with virtual health kiosks and connected diagnostic devices that allow them to better support physicians providing care virtually while building trust with community members. Discussions are also under way with federally qualified health centres (FQHCs) and other potential partners to bring this solution to more communities across the country.

The pharmacy initiative underscores Rocket Doctor AI's mission to bridge gaps in health care delivery by leveraging technology to bring high-quality care directly to where people live and work.

About Rocket Doctor AI Inc.

Rocket Doctor AI delivers physician-built, AI-powered solutions designed to make high-quality health care accessible throughout the entire patient journey. A cornerstone of the company's proprietary technology is the Global Library of Medicine (GLM), a clinically validated decision support system developed with input from hundreds of physicians worldwide.

Alongside the GLM is Rocket Doctor Inc., and its AI-powered digital health platform and marketplace. Having helped empower over 300 MDs to provide care to more than 700,000 patient visits, the company's proprietary technology software and systems enable doctors to independently launch and manage their own virtual or hybrid in-person practices -- improving efficiency, restoring autonomy to MDs and expanding patient access to care.

By reducing administrative burdens and ensuring greater consistency in care, the company's technology creates more time for meaningful physician-patient interactions. The company is committed to reaching underserved, rural and remote communities in Canada who often lack access to family doctors and supporting patients on Medicaid and Medicare in the United States. With advanced AI, large language models and connected medical devices, Rocket Doctor AI is redefining modern health care -- making it more scalable, equitable and patient centred.

We seek Safe Harbor.

© 2026 Canjex Publishing Ltd. All rights reserved.